by Admin | Aug 23, 2018 | Portfolio News
August 23, 2018 08:00 ET | Source: Allecra Therapeutics, GmbH Ready to start pivotal Phase III clinical trial Allecra secures Series C €14M financing from existing shareholders Dr. Klaus Wilgenbus appointed as CEO and Dr. Mathias Knecht as second Managing Director...
by Admin | Aug 14, 2018 | Portfolio News
August 14, 2018 The Board of Tanvex Biologics Corporation (Taiwan), a wholly owned subsidiary of Tanvex BioPharma, Inc. (TWSE: 6541) has approved to expand process development capability from 2 Liter to 250 Liter scale, leading to the manufacturing of phase I clinical...
by Admin | Jun 21, 2018 | Portfolio News
Cleveland. – June 21, 2018 – Thermalin, Inc., a privately held company with its main laboratories in Cleveland, Ohio, announced $8M in new commitments, bringing total amount of its tranched, Series A Preferred financing to $21M. This round of financing will support...
by Admin | Feb 7, 2018 | Portfolio News
Published: Feb 07, 2018 February 6, 2018 — Luqa Pharmaof Hong Kong closed a $15 million Series B financing round led by Cenova Capital. Luqa, a company that in-licenses dermatology and aesthetic products for China, plans to use the proceeds to expand its...